Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis: A novel variant of BRAF inhibitor associated panniculitis with histiocytoid infiltrate of immature neutrophils

Neutrophilic panniculitis is an infrequent but characteristic adverse event under therapy with BRAF inhibitors (BRAFi). Since the approval of vemurafenib for treatment of metastatic melanoma in 2011, only two cases of neutrophilic panniculitis in malignancies other than melanoma have been published....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Biol Ther
Hauptverfasser: Richarz, Nina Anika, Puig, Luis, Pérez, Noelia, Cuadra-Urteaga, Jose, Elez, Elena, Fernández-Figueras, Maria Teresa
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2018
Schlagworte:
Bedside to Bench Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6370375/
https://ncbi.nlm.nih.gov/pubmed/30426827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1529113
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge